PI Industries (PI)’s revenue grew 11% YoY in 4QFY24, led by a healthy growthin the CSM business (up 9% YoY) and incremental revenue from the Pharmabusiness, which was absent in 4QFY23 (revenue mix of ~4% in 4QFY24).